Abstract: The present invention relates to a formulation comprising whey protein or a hydrolysate of whey protein, which formulation is capable of inhibiting the expression of TNF? in lipopolysaccharide-stimulated macrophages in vitro. Also provided are uses of the formulation for attenuating a reduction in muscle function which results from muscle damage and/or for enhancing recovery from muscle damage and/or for enhancing the force generating capacity of muscle and methods of making the formulation.
Type:
Grant
Filed:
June 15, 2007
Date of Patent:
May 30, 2017
Assignee:
MURRAY GOULBURN CO-OPERATIVE., LIMITED
Inventors:
Michelle Rowney, Andrew Brown, Yu Pan, Jonathan David Buckley